期刊文献+

盐酸环丙沙星/二氧化硅复合粒子的原位制备及其缓释性能 被引量:3

In situ preparation of ciprofloxacin hydrochloride/silica composites and their sustained release properties
下载PDF
导出
摘要 利用硅酸钠在盐酸环丙沙星的酸溶液中的原位水解成功制备了盐酸环丙沙星/二氧化硅复合粒子.对所得产品进行的SEM、TEM、粒度分布、XRD和FTIR等分析表明,盐酸环丙沙星/二氧化硅复合粒子为粒径0.3~0.7μm的球形粒子,呈无定形态,且盐酸环丙沙星与二氧化硅以物理方式结合.热重分析结果表明,所得复合粒子药物负载量约为28.8%(质量分数).体外溶出实验证明,产品具有良好的缓释性能,药物释放主要受扩散控制,具有均匀的释放速率和持久的缓释时间. Ciprofloxacin hydrochloride/silica composites have been prepared by in situ hydrolysis of sodium silicate in an acidic ciprofloxacin hydrochloride solution. Characterization by SEM, TEM, particle size distribution, XRD and FTIR indicated that the amorphous composite particles had a spherical morphology with a diameter of 0.3- 0.7μm, and that ciprofloxacin hydrochloride was combined with silica via a physical process. Thermogravimetric analysis showed that the amount of ciprofloxacin hydrochloride entrapped in the composites was about 28. 8% (mass fraction). In vitro release studies demonstrated that the composites had excellent sustained release properties with a constant release rate and a long release period and furthermore, that the release of the drug was mainly controlled by diffusion.
出处 《北京化工大学学报(自然科学版)》 EI CAS CSCD 北大核心 2007年第5期500-503,共4页 Journal of Beijing University of Chemical Technology(Natural Science Edition)
基金 国家自然科学基金(50642042/20325621)
关键词 盐酸环丙沙星 药物缓释 原位水解 二氧化硅 复合粒子 ciprofloxacin hydrochloride drug controlled release in situ hydrolysis silica composites
  • 相关文献

参考文献12

  • 1FOURNIER E,PASSIRANI C,MONTERO-MENEI C N,et al.Biocompatibility of implantable synthetic polymeric drug carriers:Focus on brain biocompatibility[J].Biomaterials,2003,24(19):3311-3331.
  • 2OUSSOREN C,STORM G.Liposomes to target the lymphatics by subcutaneous administration[J].Advanced Drug Delivery Reviews,2001,50(1-2):143-156.
  • 3KATAOKA K,HRADA A,NAGASAKI Y.Block copolymer micelles for drug delivery:Design,characterization and biological significance[J].Advanced Drug Delivery Reviews,2001,47(1):113-131.
  • 4KORTESUO P,AHOLA M,KARLSSON S,et al.Sol-gel-processed sintered silica xerogel as a carrier in controlled drug delivery[J].Journal of Biomedical Materials Research,1999,44(2):162-167.
  • 5CHARNAY C,BEGU S,TOURNE-PETEILH C,et al.Inclusion of ibuprofen in mesoporous templated silica:Drug loading and release property[J].European Journal of Pharmaceutics and Biopharmaceutics,2004,57(3):533-540.
  • 6ZHU Yufang,SHI Jianlin,SHEN Weihua,et al.Preparation of novel hollow mesoporous silica spheres and their sustained-release property[J].Nanotechnology,2005,16(11):2633-2638.
  • 7CHEN Jianfeng,DING Haomin,WANG Jiexin,et al.Preparation and characterization of porous hollow silica nanoparticles for drug delivery application[J].Biomaterials,2004,25(4):723-727.
  • 8VALLET-REGI M,RAMILA A,DEL REAL R P,et al.A new property of MCM-41:Drug delivery system[J].Chemistry of Materials,2001,13(2):308-311.
  • 9LIU Fan,WEN Lixiong,LI Zhuzhu,et al.Porous hollow silica nanoparticles as controlled delivery system for water-soluble pesticide[J].Materials Research Bulletin,2006,41(12):2268-2275.
  • 10PEPPAS N A,BURES P,LEOBANDUNG W,et al.Hydrogels in pharmaceutical formulations[J].European Journal of Pharmaceutics and Biopharmaceutics,2000,50(1):27-46.

同被引文献28

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部